UCB NORDIC A/S: Financial statements 2017
CVR: 26688949
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
UCB NORDIC A/S (CVR 26688949) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 34,824,000 and a net result of DKK 3,739,000 compared with DKK 3,672,000 the year before. Equity in the 2017 report amounted to DKK 10,614,000. The solvency ratio was 13.1%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 34,824,000
- Profit/Loss
- DKK 3,739,000
- Equity
- DKK 10,614,000
- Total Assets
- DKK 80,784,000
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 34.8 mio. | 3.7 mio. | 10.6 mio. | 23 |
| 2016 | - | -35.5 mio. | 3.7 mio. | 10.4 mio. | 25 |
| 2015 | - | 33.7 mio. | 2.1 mio. | 8.2 mio. | - |
| 2014 | - | 33.5 mio. | 2.7 mio. | 8.8 mio. | - |
| 2013 | - | 28.9 mio. | 403 t. | 6.5 mio. | 26 |
Official annual report
Keep an eye on UCB NORDIC A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
UCB NORDIC A/S has published its annual report for 2016. Gross profit came to DKK -35,467,000, and the net result was DKK 3,672,000.
About UCB NORDIC A/S
UCB NORDIC A/S is a Danish company of the type Aktieselskab based in København S, founded in 2002. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named UCB NORDICS ApS and CELLTECH NORDIC ApS. The management consists of Mari-Ann Retz. The board consists of Laura Ann Byram (chair), Christina Dyreborg Jeppesen and Jaana Mattila. The company is owned by UCB Pharma SA. The company has 48 employees (2026). In 2025, the company reported a gross profit of DKK 88,278,000 and a net result of DKK 6,014,000 compared with DKK 5,226,000 the year before. Equity in the 2025 report amounted to DKK 18,047,000.